1189107-54-7

Basic information

• Product Name: 7-Bromo-4-hydroxy-8-methylquinoline-3-carboxylic acid
• Synonyms: 7-Bromo-4-hydroxy-8-methylquinoline-3-carboxylic acid
• CAS NO: 1189107-54-7
• Molecular Formula: C11H8BrNO3
• Molecular Weight: 282.09012
• Mol File: 1189107-54-7.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 445.7±45.0 °C(Predicted)
• Appearance: /
• Density: 1.760±0.06 g/cm3(Predicted)
• PKA: 0.69±0.30(Predicted)
• CAS DataBase Reference: 7-Bromo-4-hydroxy-8-methylquinoline-3-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 7-Bromo-4-hydroxy-8-methylquinoline-3-carboxylic acid(1189107-54-7)
• EPA Substance Registry System: 7-Bromo-4-hydroxy-8-methylquinoline-3-carboxylic acid(1189107-54-7)

Safety Data

• Hazard Codes: Xi
• Statements: 36
• Safety Statements: 26
• WGK Germany: 3
• Hazardous Substances Data: 1189107-54-7(Hazardous Substances Data)

Upstream product

• 1189107-52-5 ethyl 7-bromo-4-hydroxy-8-methylquinoline-3-carboxylate 
• 55289-36-6 3-bromo-2-methylaniline 
• 1445790-54-4 diethyl 2-(((3-bromo-2-methylphenyl)amino)methylene)-malonate 

Downstream Products

• 1445787-33-6 3-((3-carbamoyl-7-(2,4-dimethoxypyrimidin-5-yl)-8-methylquinolin-4-yl)amino)-5-cyclopentylbenzoic acid 
• 1445790-60-2 methyl 3-((7-bromo-3-carbamoyl-8-methylquinolin-4-yl)amino)-5-cyclopentylbenzoate 
• 1445790-62-4 methyl 3-((3-carbamoyl-7-(2,4-dimethoxypyrimidin-5-yl)-8-methylquinolin-4-yl)amino)-5-cyclopentylbenzoate 

Relevant articles and documents

CHEMICAL COMPOUNDS

The invention is directed to substituted quinoline derivatives. Specifically, the invention is directed to compounds according to Formula (I): wherein R1, R2, R3; R4; and R5 are defined herein. The compounds of the invention are inhibitors of lactate dehydrogenase A and can be useful in the treatment of cancer and diseases associated with tumor cell metabolism, such as cancer, and more specifically cancers of the breast, colon, prostate and lung. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting lactate dehydrogenase A activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.